Form 8-K Edwards Lifesciences For: Oct 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Edwards Lifesciences (EW) PT Raised to $122 at Oppenheimer
October 28, 2021 7:46 AM EDTOppenheimer analyst Suraj Kalia raised the price target on Edwards Lifesciences (NYSE: EW) to $122.00 (from $120.00) while maintaining an Outperform rating.
The analyst commented, "Edwards reported 3Q21 revenues of $1.31B, slightly behind our/consensus' $1.34B/$1.32B estimates, but within guidance of $1.291.37B. TAVR... More
Edwards Lifesciences (EW) PT Raised to $129 at Stifel
October 28, 2021 6:42 AM EDTStifel analyst Rick Wise raised the price target on Edwards Lifesciences (NYSE: EW) to $129.00 (from $120.00) while maintaining a Buy rating.
The analyst commented, "Despite pockets of OUS TAVR strength/recovery, US Covid impacts pushed 3Q21 revenues to $1.31B, just below Street... More
